Rising premiums and deductibles are pushing people away from traditional insurance. This isn't an abandonment of healthcare, but a market response to a product that no longer provides adequate value, forcing a shift towards cash-pay and alternative models.

The US healthcare system rewards inefficiency, with multiple parties adding costs. Cash-pay systems bypass this, offering services and drugs at a lower net price by avoiding negotiations and markups inherent in the insurance-based model.

The health insurance industry effectively transfers money from young, healthy individuals who rarely use services to older people who consume them frequently. Consequently, young people may be better off with a high-deductible, minimum coverage plan that protects against catastrophic events without overpaying into the system.

Direct-to-consumer telehealth companies like Hims achieve rapid growth via a vertically integrated model of marketing, medical groups, and pharmacies. This structure allows them to generate revenue from selling medicines, a more scalable business than relying on fees from the practice of medicine alone.

Contrary to common assumptions, Medicare patients are often the most financially protected. Private insurance plans with high deductibles can expose patients to more severe out-of-pocket costs, making them a higher-risk group for financial hardship during cancer treatment.

Legacy pharmacies like CVS and Walgreens operate within the complex, insurance-based healthcare system. DTC companies like Hims sidestep this entirely by focusing on the cash-pay market, meaning they aren't directly competing for the same customer or in the same value chain.

Life sciences companies risk obsolescence not from direct competitors, but from the tech and wellness industries. These sectors are capitalizing on patient empowerment and consumerization, innovating in ways the traditional healthcare industry has not, thereby filling the void and capturing patient trust.

For individuals with a multi-million dollar net worth, forgoing expensive health insurance can be a rational financial choice. The substantial savings on premiums (e.g., $300-400k over a decade) can create a fund large enough to cover most medical costs out-of-pocket, effectively creating a self-insurance pool.

Eli Lilly's direct-to-consumer model for GLP-1s has been a massive success, with over half of new users coming through this channel. It shows consumers crave a streamlined, digital experience and want to bypass traditional healthcare system frictions.